Next 10 |
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin ® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability. Nutrex-Hawaii...
2024-02-12 09:44:05 ET Cyanotech Corporation (CYAN) Q3 2024 Results Conference Call February 9, 2024 08:00 PM ET Company Participants Matt Custer - President and CEO Felicia Ladin - CFO Presentation Matt Custer Aloha from Kona, Hawaii. Thank you a...
2024-02-08 17:14:48 ET More on Cyanotech Financial information for Cyanotech Read the full article on Seeking Alpha For further details see: Cyanotech GAAP EPS of -$0.16, revenue of $5.58M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023. Commenting on the third...
Turnstone Biologics Corp. (TSBX) is expected to report $-0.73 for Q4 2023 Exro Technologies Inc (EXROF) is expected to report for Q4 2023 Boyd Gaming Corporation (BYD) is expected to report $1.43 for Q4 2023 Onto Innovation Inc. (ONTO) is expected to report $0.99 for Q4 2023 Motor...
2023-11-08 08:50:49 ET More on Cyanotech Financial information for Cyanotech For further details see: Cyanotech GAAP EPS of -$0.13, revenue of $6.37M
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the second quarter and first six months of fiscal year 2024, ended September 30, 2023. Commenting on the second...
Evotec SE (EVO) is expected to report $-0.03 for Q3 2023 Amplifon (AMFPF) is expected to report for Q3 2023 Compass Therapeutics Inc. (CMPX) is expected to report $-0.11 for Q3 2023 Astronics Corp. - Class B (ATROB) is expected to report for Q4 2023 Charge Enterprises Inc. (CRGE) ...
Cyanotech Corporation (CYAN) is expected to report for Q1 2024
2023-08-11 10:35:56 ET Cyanotech press release ( NASDAQ: CYAN ): Q1 GAAP EPS of -$0.22. Revenue of $5.14M (-23.5% Y/Y). For further details see: Cyanotech GAAP EPS of -$0.22, revenue of $5.14M
News, Short Squeeze, Breakout and More Instantly...
Cyanotech Corporation Company Name:
CYAN Stock Symbol:
NASDAQ Market:
Cyanotech Corporation Website:
The new gummy offers an industry-leading 12mg of Hawaiian Astaxanthin ® per serving – 6000 times the antioxidant power of Vitamin C – with science-backed, multifunctional benefits and a 40-year legacy of farm-direct transparency and traceability. Nutrex-Hawaii...
The Dow Jones index closed lower by around 100 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern a...
Cyanotech Corporation (Nasdaq Capital Market: CYAN), a world leader in microalgae-based, high-value nutrition and health dietary supplement products, announced financial results for the third quarter and first nine months of fiscal year 2024, ended December 31, 2023. Commenting on the third...